In this webinar, Daryl Cole will share insights into the high-throughput screening and analysis of antibody binding and functional characterization.

Nature Medicine has been chronicling advances in medical technology and health care. To mark the journal’s 30th anniversary, each month ...

One of the pillars of modern medicine is the life-saving drugs that pharmaceutical companies spend years developing to cure ...

Insilico Medicine ( "Insilico") , a clinical stage generative artificial intelligence (AI)-driven biotechnology company today announced a set of preclinical drug discovery benchmarks from the 22 ...

Recursion Pharmaceuticals (RXRX) is a clinical-stage biotechnology company utilizing artificial intelligence to expedite drug ...

The UK announced the funding at the AI Action Summit in Paris where it abstained from signing a declaration on an inclusive ...

Alloy Therapeutics Inc. (“Alloy”), a biotechnology ecosystem company dedicated to democratizing access to cutting edge drug ...

AI creates anti-cancer molecules for proteins that previously could not be targeted pharmacologically by leveraging quantum ...

Drug discovery has long been plagued by high costs, inefficiencies and high failure rates. Therefore, many companies are now ...

Five years since it launched, advances powered by the National Drug Discovery Centre are helping transform medical research in Australia and fast-tracking development of new home-grown treatments.

Inventia Life Science, an innovator in 3D cell culture technologies, announces the launch of RASTRUM™ Allegro, a ...

By fusing circular dichroism with high-resolution microspectroscopy and microscopic imaging, this cutting-edge technology is ...